Paroxetine Tablet, Film Coated
Product Images NDC 70518-1460

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 70518-1460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of paroxetine hydrochloride, the active ingredient in PAROXETINE 30 mg film-coated tablets by REMEDYREPACK INC. The diagram shows the molecular arrangement of atoms in paroxetine hydrochloride.*
FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
A forest plot illustrating fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) of various interacting drugs (Pimozide, Desipramine, Propranolol, Digoxin, and Phenytoin) relative to reference values. The x-axis shows the change relative to reference on a logarithmic scale from 0.1 to 10.*
FDA Label Image

Figure2.jpg (Figure2)

Figure2.jpg (Figure2)
A dot plot chart showing the pharmacokinetic interaction of various drugs on the Cmax and AUC of paroxetine hydrochloride 30 mg. The x-axis indicates fold change and 90% confidence intervals, comparing each drug's impact to a reference value of 1. The interacting drugs listed include Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam, with their dosing regimens noted on the y-axis.*
FDA Label Image

Figure3.jpg (Figure3)

Figure3.jpg (Figure3)
A pharmacokinetic fold change chart with 90% confidence intervals displaying Cmax, Cmin, and AUC values under different conditions: renal impairment (mild, moderate, severe), hepatic impairment, age over 65 years at various doses (20 mg, 30 mg, 40 mg once daily), and gender (males). The X-axis shows changes relative to the reference on a logarithmic scale from 0.5 to 50.0.*
FDA Label Image

Mm1 (Paroxetine 30mg 70518 1460 00)

Mm1 (Paroxetine 30mg 70518 1460 00)
Label for PARoxetine 30 mg film-coated tablets, quantity of 90, repackaged by RemedyRepack Inc. The label includes the NDC number 70518-1460-00, manufacturer Apotex Corp. in Weston, FL, and storage instructions. It specifies prescription use only and advises to keep out of reach of children.*
FDA Label Image

Mm2 (Paroxetine 30mg 70518 1460 01)

Mm2 (Paroxetine 30mg 70518 1460 01)
Label for PARoxetine 30 mg film-coated tablets, quantity of 100, repackaged by RemedyRepack Inc. The label includes the NDC number 70518-1460-01, manufacturer Apotex Corp., and storage instructions (20-25°C, excursions 15-30°C). The label directs users to see the package insert for directions.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Paroxetine Tablet 30 mg film-coated tablet, quantity 1. The label includes storage instructions and repackager information, showing RemedyRepack Inc. as the repackager located in Indiana, PA. The original manufacturer is Apotex Corp., Weston, FL. The label specifies the product is prescription only (RX ONLY).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.